SWA
JAZZ icon

SOA Wealth Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

SOA Wealth Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-19
Closed -$2K – 916
2022
Q1 		$2K Hold
19
– – ﹤0.01% 806
2021
Q4 		$2K Hold
19
– – ﹤0.01% 778
2021
Q3 		$2K Buy
+19
New +$2.87K ﹤0.01% 789

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

SOA Wealth Advisors's JAZZ Position: Q2 2022 in Review

SOA Wealth Advisors sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2022, closing a stake of 19 shares — an estimated $2K sold.

SOA Wealth Advisors first reported a position in JAZZ in Q3 2021 and held it in 3 quarters. The position peaked at $2K in Q1 2022. 468 funds tracked by Wall St. Rank hold JAZZ as of Q2 2022.

  • SOA Wealth Advisors reported no remaining Jazz Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • SOA Wealth Advisors sold 19 Jazz Pharmaceuticals shares in Q2 2022, an estimated $2K.
  • SOA Wealth Advisors first reported a position in Jazz Pharmaceuticals in Q3 2021 and held it in 3 quarters.
  • SOA Wealth Advisors's Jazz Pharmaceuticals position peaked at $2K in Q1 2022.
  • 468 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2022.

Based on SOA Wealth Advisors's 13F filing for Q2 2022, filed 13 Jul 2022.